A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who struggle to take daily HIV pills may benefit from long-acting injectable ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Dolutegravir is one of the most effective and safest HIV medicines and is used by millions of adults and adolescents living ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...

Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...

In the fight against HIV, one of the most vulnerable populations is often overlooked - newborn babiesIt is estimated that 120,000 new HIV infections occur in children aged 14 years and younger every ...